Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

479 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells.
Friesen C, Herr I, Krammer PH, Debatin KM. Friesen C, et al. Among authors: debatin km. Nat Med. 1996 May;2(5):574-7. doi: 10.1038/nm0596-574. Nat Med. 1996. PMID: 8616718
[The role of CD95 (APO-1/Fas) mutations in lymphoproliferative and malignant lymphatic diseases].
Beltinger C, Böhler T, Schrappe M, Ludwig WD, Debatin KM. Beltinger C, et al. Among authors: debatin km. Klin Padiatr. 1998 Jul-Aug;210(4):153-8. doi: 10.1055/s-2008-1043871. Klin Padiatr. 1998. PMID: 9743945 Review. German.
Pre-BCR signaling in precursor B-cell acute lymphoblastic leukemia regulates PI3K/AKT, FOXO1 and MYC, and can be targeted by SYK inhibition.
Köhrer S, Havranek O, Seyfried F, Hurtz C, Coffey GP, Kim E, Ten Hacken E, Jäger U, Vanura K, O'Brien S, Thomas DA, Kantarjian H, Ghosh D, Wang Z, Zhang M, Ma W, Jumaa H, Debatin KM, Müschen M, Meyer LH, Davis RE, Burger JA. Köhrer S, et al. Among authors: debatin km. Leukemia. 2016 Jun;30(6):1246-54. doi: 10.1038/leu.2016.9. Epub 2016 Feb 5. Leukemia. 2016. PMID: 26847027 Free PMC article.
Apoptosis induction in peripheral leukemia cells by remission induction treatment in vivo: selective depletion and apoptosis in a CD34+ subpopulation of leukemia cells.
Stahnke K, Eckhoff S, Mohr A, Meyer LH, Debatin KM. Stahnke K, et al. Among authors: debatin km. Leukemia. 2003 Nov;17(11):2130-9. doi: 10.1038/sj.leu.2403144. Leukemia. 2003. PMID: 14523471 Clinical Trial.
Betulinic acid-induced apoptosis in leukemia cells.
Ehrhardt H, Fulda S, Führer M, Debatin KM, Jeremias I. Ehrhardt H, et al. Among authors: debatin km. Leukemia. 2004 Aug;18(8):1406-12. doi: 10.1038/sj.leu.2403406. Leukemia. 2004. PMID: 15201849
Corticosteroid-induced chemotherapy resistance in urological cancers.
Zhang C, Mattern J, Haferkamp A, Pfitzenmaier J, Hohenfellner M, Rittgen W, Edler L, Debatin KM, Groene E, Herr I. Zhang C, et al. Among authors: debatin km. Cancer Biol Ther. 2006 Jan;5(1):59-64. doi: 10.4161/cbt.5.1.2272. Epub 2006 Jan 25. Cancer Biol Ther. 2006. PMID: 16294015
Dexamethasone desensitizes hepatocellular and colorectal tumours toward cytotoxic therapy.
Zhang C, Kolb A, Mattern J, Gassler N, Wenger T, Herzer K, Debatin KM, Büchler M, Friess H, Rittgen W, Edler L, Herr I. Zhang C, et al. Among authors: debatin km. Cancer Lett. 2006 Oct 8;242(1):104-11. doi: 10.1016/j.canlet.2005.10.037. Epub 2005 Dec 9. Cancer Lett. 2006. PMID: 16338063
Apoptosis mediated by lentiviral TRAIL transfer involves transduction-dependent and -independent effects.
Wenger T, Mattern J, Haas TL, Sprick MR, Walczak H, Debatin KM, Büchler MW, Herr I. Wenger T, et al. Among authors: debatin km. Cancer Gene Ther. 2007 Mar;14(3):316-26. doi: 10.1038/sj.cgt.7701016. Epub 2006 Dec 22. Cancer Gene Ther. 2007. PMID: 17186015
Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy.
Fulda S, Debatin KM. Fulda S, et al. Among authors: debatin km. Oncogene. 2006 Aug 7;25(34):4798-811. doi: 10.1038/sj.onc.1209608. Oncogene. 2006. PMID: 16892092 Review.
Dexamethasone-induced cisplatin and gemcitabine resistance in lung carcinoma samples treated ex vivo.
Gassler N, Zhang C, Wenger T, Schnabel PA, Dienemann H, Debatin KM, Mattern J, Herr I. Gassler N, et al. Among authors: debatin km. Br J Cancer. 2005 Mar 28;92(6):1084-8. doi: 10.1038/sj.bjc.6602453. Br J Cancer. 2005. PMID: 15756274 Free PMC article.
479 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback